The Future of Clinical Trials and Pharmacovigilance
3 years ago
By Josh Neil
This year, Proventa debuted its successful online event format for the first time, providing experts from across the sector with an online forum just as useful and educational as our physical events have always been. During the recent Clinical Trials/Pharmacovigilance events, held on 25 June, delegates received the chance to not only discover new insights in their chosen profession but also make important connections and engage with peers through the interactive roundtable discussions and panel debates.
After the event, several facilitators relayed what they thought the main obstacles and themes of the next five years will be. These ranged from the problem of COVID-19 and safety, to how AI will change clinical trials and pharmacovigilance over the coming years.
If you’re unable to see the below PDF, click here.
For more information on future events, including the upcoming Clinical Operations, CTSC and Pharmacovigilance meetings in November 2020, click here.
Joshua Neil, Editor
Proventa International
Raising Representation in Clinical Trials: An Interview with Liz Beatty, Inato
The COVID-19 pandemic created a significant shortage of suitable patients for clinical trials worldwide. Within this crisis was another more serious issue around inclusion and representation, driven by COVID’s disparate effect on certain ethnicities, that spoke to a wider issue...
2 years agoRaising Representation in Clinical Trials: An Interview with Liz Beatty, Inato
The COVID-19 pandemic created a significant shortage of suitable patients for clinical trials worldwide. Within this crisis was another more serious issue around inclusion and representation, driven by COVID’s disparate effect on certain ethnicities, that spoke to a wider issue...
2 years ago
DeepMind’s AI Predicts Structures for More Than 350,000 Proteins
In 2003, researchers sequenced approximately 92% of the human genome, a huge achievement and very recently researchers have completed the entire process. Now, the latest innovation in AI technology has predicted the structure of nearly the entire human proteome. The...
2 years agoDeepMind’s AI Predicts Structures for More Than 350,000 Proteins
In 2003, researchers sequenced approximately 92% of the human genome, a huge achievement and very recently researchers have completed the entire process. Now, the latest innovation in AI technology has predicted the structure of nearly the entire human proteome. The...
2 years ago
COVID-19 Booster Controversy: Disputes Across the Pharma Industry
Despite almost two thirds of the adult population in the UK having been vaccinated, cases are on the rise, which appear to be associated with the highly-transmissible delta variant of COVID-19. According to The European Centre for Disease Prevention and Control,...
2 years agoCOVID-19 Booster Controversy: Disputes Across the Pharma Industry
Despite almost two thirds of the adult population in the UK having been vaccinated, cases are on the rise, which appear to be associated with the highly-transmissible delta variant of COVID-19. According to The European Centre for Disease Prevention and Control,...
2 years ago